{"transactions":[{"id":719815,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":33404,"kind":"person","name":"Amin Dipti","position":1,"cik":"0001856708","reported_name":"Amin Dipti","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-02T21:00:08.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will vest and become exercisable on the earlier of July 1, 2027 and the date of the issuer's next annual meeting of shareholders, subject in any case to the reporting person's continuous service with the issuer."}],"balance_after":125000,"derivative":{"exercise_price":1.3,"expiration_date":"2036-07-01","underlying":"Common Shares","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001193125-26-294852","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000119312526294852/ownership.xml","form_type":"4"}},{"id":1096710,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":33404,"kind":"person","name":"Amin Dipti","position":1,"cik":"0001856708","reported_name":"Amin Dipti","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-03T01:00:11.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will vest and become exercisable on the earlier of July 1, 2026 and the date of the issuer's next annual meeting of shareholders, subject in any case to the reporting person's continuous service with the issuer."}],"balance_after":75000,"derivative":{"exercise_price":0.8977,"expiration_date":"2035-07-01","underlying":"Common Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000950170-25-093470","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000095017025093470/ownership.xml","form_type":"4"}},{"id":1461366,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":33404,"kind":"person","name":"Amin Dipti","position":1,"cik":"0001856708","reported_name":"Amin Dipti","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-03T21:00:03.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will vest and become exercisable on July 1, 2025, subject to the reporting person's continuous service with the issuer."}],"balance_after":75000,"derivative":{"exercise_price":0.9541,"expiration_date":"2034-07-01","underlying":"Common Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000950170-24-081603","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000095017024081603/ownership.xml","form_type":"4"}},{"id":1840351,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":33404,"kind":"person","name":"Amin Dipti","position":1,"cik":"0001856708","reported_name":"Amin Dipti","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-03T21:46:09.000Z","date":"2023-07-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will vest and become exercisable on July 1, 2024, subject to the reporting person's continuous service with the issuer."}],"balance_after":50000,"derivative":{"exercise_price":1.41,"expiration_date":"2033-07-01","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-23-023342","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315223023342/ownership.xml","form_type":"4"}},{"id":2213190,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":33404,"kind":"person","name":"Amin Dipti","position":1,"cik":"0001856708","reported_name":"Amin Dipti","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-06T20:15:31.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will vest and become exercisable on July 1, 2023, subject to the reporting person's continuous service with the issuer."}],"balance_after":50000,"derivative":{"exercise_price":1.57,"expiration_date":"2032-07-01","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-22-018687","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315222018687/ownership.xml","form_type":"4"}},{"id":2315956,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":33404,"kind":"person","name":"Amin Dipti","position":1,"cik":"0001856708","reported_name":"Amin Dipti","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares, no par value","published_at":"2022-03-29T20:15:32.000Z","date":"2022-03-28","kind":"purchase","acquired":true,"shares":35000,"price":1.63,"value":57050.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average. The shares were purchased in multiple transactions at prices ranging from not less than $1.48 to not more than $1.66. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001493152-22-008029","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315222008029/ownership.xml","form_type":"4"}},{"id":2648700,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":33404,"kind":"person","name":"Amin Dipti","position":1,"cik":"0001856708","reported_name":"Amin Dipti","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-01T22:26:24.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will vest and become exercisable on July 1, 2022, subject to the reporting person's continuous service with the issuer."}],"balance_after":50000,"derivative":{"exercise_price":2.86,"expiration_date":"2031-07-01","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-21-015888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221015888/ownership.xml","form_type":"4"}},{"id":2742411,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":33404,"kind":"person","name":"Amin Dipti","position":1,"cik":"0001856708","reported_name":"Amin Dipti","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-22T21:05:57.000Z","date":"2021-04-20","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in 36 monthly installments beginning on the one-month anniversary of the date of grant, subject to the reporting person's continuous service on the board of directors of the issuer."}],"balance_after":90000,"derivative":{"exercise_price":2.28,"expiration_date":"2031-04-19","underlying":"Common Shares","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001493152-21-009476","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000149315221009476/ownership.xml","form_type":"4"}}]}